NCT05819593View on ClinicalTrials.gov

Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2026

Conditions
Anaplastic Thyroid Cancer
Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05819593 - Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences | Biotech Hunter | Biotech Hunter